|
|
Neovasc Incorporation - Comparative Business Analysis Snapshot
Business Description
Neovasc Incorporation Formerly known as Medical Ventures Corp.. The Group's principal activities is to acquire, develop and commercialize medical technologies. The products of the Group include the Neovasc Reducer for refractory angina and PeriPatch surgical tissue. The Neovasc Reducer provides treatment for patients with refractory angina. Refractory angina patients have severe, debilitating chest pain due to insufficient blood supply to the heart muscle that is not amenable to revascularization. PeriPatch is a flexible collagen-tissue patch cut from a uniform area of chemically treated bovine or equine pericardium. It is used for cardiac reconstruction and repair, soft tissue repair and general surgical procedures. On 01-Jul-2008, the Group acquired Neovasc Medical and B-Balloon.
Competitor Analysis
This analysis compares Neovasc Incorporation with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
